Gaxos.ai (NASDAQ: GXAI) boosts ATM stock sale by $2.6M

Rhea-AI Filing Summary

Gaxos.ai Inc. is offering up to an additional $2,600,000 of common stock under its at-the-market Sales Agreement with H.C. Wainwright & Co.

The company previously sold 1,515,700 shares for gross proceeds of approximately $3,000,000 under this agreement. As of February 3, 2026, it had 8,639,153 shares outstanding and a public float of 8,416,721 shares valued at about $16,833,442 at $2.00 per share. Under Form S-3 General Instruction I.B.6, it may offer shares with an aggregate offering price of up to approximately $2,611,395.

Filed Pursuant to Rule 424(b)(5)

Registration No. 333-283758

PROSPECTUS SUPPLEMENT

(To Prospectus dated December 18, 2024

To Prospectus Supplement dated January 23, 2026)

Up to $2,600,000

Common Stock

 

Gaxos.ai Inc.

This prospectus supplement (“Prospectus Supplement”) amends and supplements the information in the prospectus, dated December 18, 2024, filed as a part of our registration statement on Form S-3 (File No. 333-283758), as supplemented by our prospectus supplement dated January 23, 2026 (collectively, the “Prior Prospectus”). This prospectus supplement should be read in conjunction with the Prior Prospectus, and is qualified by reference thereto, except to the extent that the information herein amends or supersedes the information contained in the Prior Prospectus. This Prospectus Supplement is not complete without, and may only be delivered or utilized in connection with, the Prior Prospectus, and any future amendments or supplements thereto.

We filed the Prior Prospectus to register the offer and sale of our common stock, par value $0.0001 per share, from time to time pursuant to the terms of that certain At The Market Offering Agreement, dated January 23, 2026 (the “Sales Agreement”), with H.C. Wainwright & Co., LLC, (the “Sales Agent” or “Wainwright”), acting as the agent, and us.

Since our entry into the Sales Agreement, we have offered and sold 1,515,700 shares of common stock for gross proceeds of approximately $3,000,000 million pursuant to the Sales Agreement.

We are filing this Prospectus Supplement to supplement the Prior Prospectus to increase the aggregate amount we intend to sell pursuant to the Sales Agreement. As of the date of this Prospectus Supplement, we are offering up to an additional aggregate of $2,600,000 of our common stock for sale under the Sales Agreement, not including the shares of common stock previously sold pursuant to the Sales Agreement.

Our common stock is listed on the Nasdaq Capital Market under the symbol “GXAI.” On February 3, 2026, the last reported sale price of our common stock was $2.00 per share.

As of the date of this prospectus supplement, the aggregate market value of our common stock held by non-affiliates of our public float was approximately $16,833,442 based on a total number of 8,639,153 shares of common stock outstanding, of which 8,416,721 shares of common stock were held by non-affiliates, at a price of $2.00 per share, the closing sales price of our common stock on February 3, 2026, which is the highest closing price of our common stock on Nasdaq Capital Market within the prior 60 days. We have sold approximately $3,000,000 of securities pursuant to General Instruction I.B.6 of Form S-3 during the prior 12-calendar month period that ends on and includes the date of this prospectus supplement (excluding this offering). Accordingly, based on the foregoing, we are currently eligible under General Instruction I.B.6 of Form S-3 to offer and sell shares of our Common Stock having an aggregate offering price of up to approximately $2,611,395. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell securities in a public primary offering with a value exceeding one-third of our public float in any 12-month period so long as our public float remains below $75.0 million.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying base prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

H.C. Wainwright & Co.

The date of this prospectus supplement is February 4, 2026

FAQ

What does Gaxos.ai (GXAI) disclose in this 424B5 prospectus supplement?

Gaxos.ai is increasing the size of its at-the-market stock offering. The company may now sell up to an additional $2,600,000 of common stock under its existing Sales Agreement with H.C. Wainwright & Co., supplementing amounts previously registered and sold.

How much additional common stock can Gaxos.ai (GXAI) sell under the ATM program?

Gaxos.ai can sell up to an additional $2,600,000 of common stock. This amount is on top of 1,515,700 shares already sold for approximately $3,000,000 under the same at-the-market Sales Agreement with H.C. Wainwright & Co.

How much has Gaxos.ai (GXAI) already raised through the Sales Agreement?

Gaxos.ai has raised approximately $3,000,000 through prior ATM sales. These proceeds came from selling 1,515,700 shares of common stock under the Sales Agreement before this supplement increased the additional amount available for future sales.

What is Gaxos.ai’s (GXAI) current public float and share count?

Gaxos.ai’s public float is about $16,833,442. This is based on 8,416,721 non-affiliate shares at $2.00 per share, with 8,639,153 total shares of common stock outstanding as of the February 3, 2026 reference price.

How does Form S-3 General Instruction I.B.6 limit Gaxos.ai’s offering size?

Form S-3 General Instruction I.B.6 caps primary offerings at one-third of public float. Based on its current float and past $3,000,000 sales, Gaxos.ai may offer common stock with an aggregate offering price of up to approximately $2,611,395.

On which exchange is Gaxos.ai (GXAI) listed and what was the recent price?

Gaxos.ai’s common stock trades on the Nasdaq Capital Market under “GXAI.” The last reported sale price referenced in the supplement was $2.00 per share on February 3, 2026, which was also the highest closing price in the prior 60 days.